Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Dr. Reddy's acquires eight US ANDAs from Teva

18 Jun 2018

Executive Summary

Dr. Reddy's Laboratories Ltd. acquired a portfolio of eight Abbreviated New Drug Applications in the US from Teva Pharmaceutical Industries Ltd. for $350mm in cash. The products include buprenorphine/naloxone sublingual film, ethinyl estradiol/etonogestrel vaginal ring, ezetimibe/simvastatin tablets, metformin/saxagliptin ER tablets, tobramycin inhalation solution, phentermine/topiramate ER capsules, imiquimod topical cream, and ramelteon tablets.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Product Purchase

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By